AI-Generated Summary

Viva Biotech has received Frost & Sullivan's 2025 APAC Technology Innovation Leadership recognition for its pioneering AI-driven drug discovery platforms. These platforms integrate artificial intelligence with wet lab validation to significantly accelerate preclinical R&D timelines and reduce costs. The award highlights Viva Biotech's role in reshaping the future of drug discovery through scalable, intelligent innovation.

In a nutshell

This recognition underscores the increasing importance of AI in transforming pharmaceutical R&D, offering a blueprint for more efficient and cost-effective drug development. For industry professionals, it signals a critical shift towards integrated AI platforms as key drivers of future therapeutic innovation.

Source: PR Newswire UK